Information is limited regarding the relative contribution of measures of blood pressure to the long-term risk of cardiovascular disease in individuals who do not meet the criteria for hypertension. One of these measures of blood pressure, pulse pressure, is considered a marker of stiffness of the arteries and/ or atherosclerosis. [6] [7] [8] [9] Pulse pressure predicts future development of cardiovascular disease 6, [10] [11] [12] [13] [14] [15] and may be the most relevant measure of blood pressure in older individuals. 14, 15 Pulse pressure increases cardiovascular risk even in normotensive individuals. 16, 17 Moreover, widened pulse pressure is associated with prevalent diabetes 18 and widened pulse pressure plus heart rate with incident diabetes. 19 It is not known, however, the effect of pulse pressure on the relation of pre hypertension to mortality. Therefore, we examined this effect in participants in the San Antonio Heart Study who were free of hypertension, diabetes, and cardiovascular disease at the time of their enrollment.
Methods
Subjects. The San Antonio Heart Study is a longitudinal, epidemiological study designed to study type 2 diabetes and cardiovascular disease among Mexican Americans and nonHispanic whites living in San Antonio, TX. Protocols were approved by the Institutional Review Board of the University of Texas Health Science Center at San Antonio. Details of the study design have been previously published. 19, 20 Briefly, all Mexican Americans and non-Hispanic whites (men and nonpregnant women) aged 25-64 years who resided in randomly selected households from low-, middle-, and high-income census tracts were invited to participate. A total of 5,158 individuals (response rate was 65.3%) were enrolled in two phases: cohort 1, from January 1979 to December 1982; cohort 2, from January 1984 to December 1988. All subjects gave written informed consent.
Data collection. Standardized interview questionnaires were administered to gather information on socio-demographic variables, current cigarette smoking, treatment for diabetes and hypertension, and history of cardiovascular disease. Anthropometric measurements, heart rate, blood pressure, and blood specimens were obtained by trained personnel. Training of blood pressure technicians followed the Hypertension Detection and Follow-up Program guidelines, including matching proper cuff size to upper arm circumference. 21 At the day of the baseline examination, SBP (first phase) and DBP (fifth phase) were recorded using a random zero sphygmomanometer to the nearest even digit on the right arm of the seated participant after at least a 5-min rest period with the participant in the sitting position. Three readings were obtained for each participant and reported as the mean of the 2nd and 3rd readings. 19 Participants were asked to fast for 12-14 h prior to the examination visit. Blood specimens were collected prior and 2 h after a 75 g oral glucose load (Orangedex; Custom Laboratories, Baltimore, MD) for plasma glucose determination. Plasma glucose and serum lipids were measured with an Abbott Bichromatic Analyzer (Abbott Diagnostics, South Pasadena, CA).
Individuals with SBP ≥140 mm Hg and/or DBP ≥90 mm Hg and/or treatment with antihypertensive medications were considered to have hypertension. We categorized normotensive individuals using JNC 7 categories (normal (SBP <120 mm Hg and DBP <80 mm Hg) and prehypertension (SBP 120-139 mm Hg and/or DBP 80-89 mm Hg)) (ref. 1) or JNC 6 categories (optimal (SBP <120 mm Hg and DBP <80 mm Hg), normal (SBP 120-129 mm Hg and/or DBP 80-85 mm Hg), and borderline (SBP 130-139 mm Hg and/or DBP 85-89 mm Hg)). 4 Pulse pressure was defined as SBP minus DBP. Individuals with fasting plasma glucose concentration ≥126 mg/dl, 2-h plasma glucose concentration ≥ 200 mg/dl, and/or pharmacologic treatment with glucose lowering agents were considered to have diabetes. 22 History of cardiovascular disease was defined as selfreported heart attack, stroke, coronary revascularization procedure, and angina (by Rose Angina questionnaire). 23 We used the American Heart Association/National Heart, Lung, and Blood Institute definition of the metabolic syndrome. 24 Ascertainment of mortality. Ascertainment of mortality was initiated in 1999. Questionnaires were mailed annually to be completed by each participant, or his or her next of kin. In cases of no response, a participant's vital status was determined using telephone interviews, home visits, voting records, driver registration, the National Death Index, and addresses from the San Antonio Retail Merchants' Association. Ascertainment of mortality was closed on 1 January 2000. Vital status was obtained in 5,126 participants (ascertainment rate, 99.4%). 20 The cause of death was obtained from death certificates. Death certificates with names and ethnic identifiers suppressed were sent to a certified nosologist (Medical Coding and Consultation Services, Rolesville, NC) for coding according to the International Classification of Diseases, Ninth Revision (ICD-9). 20 Cardiovascular mortality was not limited to the underlying cause of death, but was defined as death with the mention anywhere on the death certificate of ICD-9 codes 401-405 (hypertensive), 410-414 (ischemic), and 420-429 (other cardiovascular), with the exception of 427.5 (cardiac arrest), 430-439 (stroke), or 440-447 (arteries and so forth). There were 548 deaths (10.7%). Cardiovascular disease was the cause of death in 261 individuals.
Statistical analyses.
Statistical analyses were performed with the SAS statistical software (SAS Institute, Cary, NC). We examined age-, sex-, and ethnic origin-adjusted baseline characteristics using two-way analysis of covariance for continuous variables and logistic regression analysis for dichotomous variables. Mortality rates were calculated using 1,000 person-years as the unit of analysis. The relationship between measures of blood pressure and mortality was assessed by Cox proportional hazard models. Hazard ratios (HRs) were adjusted for relevant risk factors including age, sex, ethnic origin, education, body mass index (BMI), current cigarette smoking, and total cholesterol concentration. In different models, appropriate interaction terms were introduced to model interactions between blood pressure and sex (or blood pressure and ethnic origin) in relation to mortality. All probability values were two-sided. P values < 0.05 were considered statistically significant.
results
We excluded participants with prevalent hypertension, diabetes, and/or cardiovascular disease at baseline (n = 1,412) as well as those with missing information on baseline variables (n = 86) or mortality (n = 28 and 80 participants for all-cause and cardiovascular mortality, respectively). Therefore, the relation of measures of blood pressure to all-cause and cardiovascular mortality was examined in 3,632 (97.0%) and 3,580 (95.6%) individuals, respectively.
The rate of prehypertension was 31.6%. Prehypertension was associated with male gender, older age, Mexican-American ethnic origin, nonsmoking status, lower education, and the metabolic syndrome ( Table 1) . Prehypertension was also more prevalent with lower high-density lipoprotein-cholesterol concentration and higher heart rate, BMI, waist circumference, and levels of total and low-density lipoprotein-cholesterol, triglycerides, and fasting glucose. Individuals with prehypertension had more widened pulse pressure than those with normal blood pressure. After accounting for the effect of articles Pulse Pressure and Mortality prehypertension, pulse pressure was associated with older age, male gender, smoking, lower education, and fasting glucose concentration. Pulse pressure was not related to heart rate, metabolic syndrome, or dyslipidemia other than lower highdensity lipoprotein-cholesterol concentration.
There were 218 deaths (mean, 15.2 years; 55,177 personyears) (3.9 deaths per 1,000 person-years) and 67 of those were attributed to cardiovascular disease (54,545 person-years; 1.2 deaths per 1,000 person-years). Individuals were grouped by tertiles of measures of blood pressure ( Table 2) . SBP was associated with all-cause mortality independently of the effect of confounding variables (P for trend <0.01), and so was pulse pressure for all-cause (P for trend <0.01) and cardiovascular mortality (P for trend <0.05). DBP was not significantly associated with mortality.
Prehypertension predicted all-cause (HR 1.49 (1.12 -1.99)) and cardiovascular mortality (HR 1.79 (1.07-3.02)) after adjusting for age, sex, ethnic origin, education, BMI, cigarette smoking, and total cholesterol concentration. In separate models, age, sex, or ethnic origin did not have significant interactions on the relation of prehypertension to all-cause mortality (Figure 1) . However, there was a significant interaction between prehypertension and age (and between prehypertension and sex) in relation to cardiovascular mortality. Age, sex, ethnicity, education, body mass index, smoking, and total cholesterol concentration were included in all models. Numerators and denominators for each category are number of deaths and total number of participants at risk, respectively. P for interaction indicates the effect of age, sex, or ethnicity on the relationship between prehypertension and mortality.
articles
Pulse Pressure and Mortality
To assess the relative contribution of pulse pressure to mortality, a Cox model was fitted with prehypertension and pulse pressure as independent variables ( Table 3) . Prehypertension was not significantly associated with mortality, but pulse pressure was related to all-cause mortality. Additionally, a second model was fitted with JNC 6 categories and pulse pressure. SBP 130-139 mm Hg and/or DBP 85-89 mm Hg was associated with increased mortality, all-cause and cardiovascular, and pulse pressure was too for all-cause mortality. In separate models, we found no sufficient evidence of interaction between pulse pressure (tertiles) and JNC 6 categories for mortality (all-cause, 0.72; cardiovascular, P = 0.30), nor between pulse pressure (tertiles) and prehypertension for all-cause mortality (P = 0.99). However, interaction terms prehypertension × pulse pressure (tertiles) were close to significance for cardiovascular mortality (P = 0.09). Pulse pressure predicted cardiovascular mortality in individuals with prehypertension (P < 0.05) but not in those with normal blood pressure (P = 0.45).
To further examine the effect of pulse pressure, we grouped individuals according to their prehypertension and pulse pressure (tertile) status (Table 4) . Prehypertension was associated with increased mortality only if pulse pressure was widened. Classifying individuals by prehypertension status and DBP categories was less informative. Nevertheless, mortality was increased in individuals with prehypertension and DBP <70 mm Hg.
discussion
Our results indicate that prehypertension is an independent predictor of all-cause and cardiovascular mortality in participants who are free of diabetes and cardiovascular disease. However, prehypertension is not a risk factor for mortality if pulse pressure is narrow. Pulse pressure is an independent predictor of mortality.
Prehypertension increased the risk of future cardiovascular events in women in the Women's Health Initiative who were free of cardiovascular disease. 3 Our results also indicate that prehypertension is an independent predictor of all-cause and cardiovascular mortality in participants who are free of diabetes and cardiovascular disease. However, analyses of heterogeneity suggest that prehypertension may be a less relevant risk factor for cardiovascular mortality in women and older individuals. A relatively small number of cardiovascular deaths is an alternative explanation, which is in agreement with the significant relationship between prehypertension and all-cause mortality in all regardless of age, sex, and ethnic origin.
Prehypertension is not a risk factor for mortality if pulse pressure is narrow. Multiple epidemiological and interventional studies indicate that there is a J-shaped relationship between DBP, and cardiovascular morbidity and mortality. 15, [25] [26] [27] [28] [29] [30] To be precise, cardiovascular risk increases when the DBP falls below a certain threshold. Low DBP is associated with carotid stenosis in subjects with isolated systolic hypertension 9 and with coronary artery calcium in postmenopausal women. 31 Several pathophysiological mechanisms have been suggested to explain the J-shaped phenomenon. 30 Low DBP may reflect the presence of a clinical or subclinical comorbid condition (especially heart disease or cancer). Low DBP may contribute to inadequate coronary perfusion and so predispose to 18  25  32  47  39  57  141   21  12  20  35  32  26  31  23  18  489 508 538 547 517 417 322 188 106   41  43  54  37  27  16  830 786 923 648 324 121  229  404  621 articles Pulse Pressure and Mortality coronary ischemia. Finally, low DBP may signal the presence of widened pulse pressure, which is a surrogate of arterial stiffness and/or atherosclerosis. In our study, there is also a relationship between low DBP and mortality, both all-cause and cardiovascular. Nevertheless, low DBP predicts mortality as long as low DBP signals widened pulse pressure.
Pulse pressure predicts future development of cardiovascular disease and may be the most relevant measure of blood pressure in older individuals. 12, 15 Furthermore, men who do not have hypertension but have high pulse pressure may have similar cardiovascular risk to hypertensive men who have low pulse pressure. 16, 17 In our analysis, pulse pressure is an independent risk factor for mortality in individuals free of hypertension, diabetes, and cardiovascular disease. Several pathogenetic mechanisms may contribute to the relationship between pulse pressure and mortality. 32 First, widened pulse pressure may select a group of individuals who are more susceptible to generalized vascular damage and atherosclerosis.
Widened pulse pressure predisposes to carotid stenosis, 9 coronary artery calcium, 31 myocardial infarction, 6, 14, 17 left ventricular hypertrophy, 33 impaired ventricular relaxation, 34 left atrial enlargement, 35 and atrial fibrillation. 18 Second, pulse pressure reflects increased arterial stiffness, which causes SBP to increase and DBP to decrease by shifting the phenomenon of wave reflection from diastole to systole. Worsening SBP has deleterious effects on myocardial oxygen demands and the risk of future hypertension. A decrease in DBP may compromise diastolic perfusion time and coronary perfusion as a consequence. Finally, widened pulse pressure may reflect the presence of a clinical or subclinical comorbid condition (e.g., aortic insufficiency).
JNC 6 categories of blood pressure may be superior to JNC 7 categories (prehypertension status) for classifying normotensive individuals according to their mortality risk. As blood pressure approaches the hypertensive level, mortality increases, a finding that was previously described by Vasan et al. 36 and Benetos et al. 16 . In these reports, there was a trend for increased cardiovascular risk for SBP 120-129 mm Hg and/ or DBP 80-84 mm Hg, but the confidence intervals overlapped the risk for SBP <120 mm Hg and DBP <80 mm Hg. Similarly, we observe a nonsignificant trend toward increased mortality, both all-cause and cardiovascular mortality, in individuals with SBP 120-129 mm Hg and/or DBP 80-84 mm Hg. Clearly, mortality is not increased in individuals with SBP 120-124 mm Hg and/or DBP 80-84 mm Hg. Because this group of individuals account for 42.4% of those with prehypertension, further research is needed to determine the optimal cut-points for prehypertension.
Pulse pressure is not related to heart rate, smoking, or most metabolic abnormalities after taking into consideration the effect of prehypertension. Relative to individuals with normal blood pressure and pulse pressure in the lower tertile, mortality is increased in individuals with prehypertension and pulse pressure in the upper tertile but is not increased in those with prehypertension and low pulse pressure in the lower tertile. These differences in mortality cannot be explained by differences in risk factors including smoking, pulse pressure, and metabolic abnormalities except for SBP and pulse pressure.
Our study has several significant limitations. First, the number of cardiovascular deaths is relatively small. Second, death certificates may not accurately reflect the cause of death. Nevertheless, it is likely that these two limitations have a minimal effect on our conclusions. There is a remarkable consistency in our analyses of cardiovascular and all-cause mortality. Both cardiovascular and all-cause mortality have been analyzed, and the total number of deaths is more than three times the number of cardiovascular deaths. All-cause mortality is free of ascertainment bias, and our analysis includes 97.0% of all potentially eligible participants. Moreover, we demonstrated no interactions on the relationship between prehypertension and all-cause mortality. An additional limitation is the possibility of misclassification of prehypertension. The JNC 7 criteria require multiple blood pressure measurements articles Pulse Pressure and Mortality during at least two separate visits for blood pressure staging, but we only obtained three blood pressure measurements at a single baseline visit. This limitation, however, is present in most epidemiological studies. In summary, prehypertension increases mortality risk in individuals who are free of diabetes and cardiovascular disease. Nevertheless, prehypertension may not be a risk factor for mortality in individuals with narrow pulse pressure. Therefore, pulse pressure, a marker of generalized vascular damage early in the disease process, may be a relevant parameter for the definition of normal blood pressure. 
